The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Anderson, E. N. (1977) · eScholarship (California Digital Library) · Cited by 2,567
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Searching for Peptide Ligands with an Epitope Library
Scott, J. K., & Smith, G. P. (1990) · Science · doi:10.1126/science.1696028 · Cited by 2,084
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Yeast surface display for screening combinatorial polypeptide libraries
Boder, E. T., & Wittrup, K. D. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-553 · Cited by 1,760
Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5879 · Cited by 1,593
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Kershaw, M. H., Westwood, J. A., Parker, L. L., Wang, G., Eshhar, Z., Mavroukakis, S. A., White, D. E., Wunderlich, J. R., Canevari, S., Rogers-Freezer, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1183 · Cited by 1,254
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,246
Making antibody fragments using phage display libraries
Clackson, T., Hoogenboom, H. R., Griffiths, A. D., & Winter, G. (1991) · Nature · doi:10.1038/352624a0 · Cited by 1,203
In vitro selection and evolution of functional proteins by using ribosome display
Hanes, J., & Plückthun, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4937 · Cited by 1,088
Arming antibodies: prospects and challenges for immunoconjugates
Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-309 · Cited by 1,027
Selecting and screening recombinant antibody libraries
Hoogenboom, H. R. (2005) · Nature Biotechnology · doi:10.1038/nbt1126 · Cited by 973
Isolating and engineering human antibodies using yeast surface display
Chao, G., Lau, W. L., Hackel, B. J., Sazinsky, S. L., Lippow, S. M., & Wittrup, K. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.94 · Cited by 909
Antibody Pharmacokinetics and Pharmacodynamics
Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909
"Diabodies": small bivalent and bispecific antibody fragments.
Holliger, P., Prospero, T., & Winter, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6444 · Cited by 874
Antibody-selectable filamentous fd phage vectors: affinity purification of target genes
Parmley, S. F., & Smith, G. P. (1988) · Gene · doi:10.1016/0378-1119(88)90495-7 · Cited by 867
Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wölle, J., Plückthun, A., & Virnekäs, B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3444 · Cited by 728 · cited 4×
“Based on a different design concept, three synthetic human combinatorial antibody libraries (HuCAL) have been described, the HuCAL-scFv (Knappik et al., 2000), the HuCAL-Fab1 (Rauchenberger et al., 2003) and the HuCAL GOLD (Rothe et al., 2008), that use preassembled trinucleotides, rather than standard mononucleotides…”
InfluentialTill, B. G., Jensen, M. C., Wang, J., Chen, E. Y., Wood, B. L., Greisman, H. A., Qian, X., James, S. E., Raubitschek, A., Forman, S. J., et al. (2008) · Blood · doi:10.1182/blood-2007-12-128843 · Cited by 722
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
Boder, E. T., Midelfort, K. S., & Wittrup, K. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170297297 · Cited by 673
Burton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Antibody arrays for high-throughput screening of antibody–antigen interactions
de Wildt, R. M. T., Mundy, C. R., Gorick, B. D., & Tomlinson, I. M. (2000) · Nature Biotechnology · doi:10.1038/79494 · Cited by 624
Stability engineering of antibody single-chain Fv fragments
Wörn, A., & Plückthun, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4265 · Cited by 616
Pastan, I., Hassan, R., FitzGerald, D. J., & Kreitman, R. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1891 · Cited by 528
Strasser, R., Stadlmann, J., Schähs, M., Stiegler, G., Quendler, H., Mach, L., Glössl, J., Weterings, K., Pabst, M., & Steinkellner, H. (2008) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2008.00330.x · Cited by 520
Antibody-antigen interactions: new structures and new conformational changes
Wilson, I. A., & Stanfield, R. L. (1994) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(94)90267-4 · Cited by 515
MODOMICS: a database of RNA modification pathways
Dunin-Horkawicz, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj084 · Cited by 508
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y. G., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508
Kowolik, C. M., Topp, M. S., Gonzalez, S., Pfeiffer, T., Olivares, S., Gonzalez, N., Smith, D. D., Forman, S. J., Jensen, M. C., & Cooper, L. J. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0160 · Cited by 487
A comparison of strategies to stabilize immunoglobulin Fv-fragments
Glockshuber, R., Malia, M., Pfitzinger, I., & Plueckthun, A. (1990) · Biochemistry · doi:10.1021/bi00458a002 · Cited by 473
Sheets, M. D., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., & Marks, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6157 · Cited by 438
Hoogenboom, H. R., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90894-p · Cited by 429
The humanization of N-glycosylation pathways in yeast
Wildt, S., & Gerngross, T. U. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1087 · Cited by 393
Yeast surface display for protein engineering and characterization
Gai, S. A., & Wittrup, K. D. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.08.012 · Cited by 389
Immunotoxin Treatment of Cancer
Pastan, I., Hassan, R., FitzGerald, D. J., & Kreitman, R. J. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.070605.115320 · Cited by 359
Borsi, L., Balza, E., Bestagno, M., Castellani, P., Carnemolla, B., Biro, A., Leprini, A., Sepulveda, J., Burrone, O., Neri, D., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10662 · Cited by 355
Phage display technology: clinical applications and recent innovations
Azzazy, H. M. E., & Highsmith, W. E. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00343-0 · Cited by 351
Expression and assembly of a fully active antibody in algae
Mayfield, S. P., Franklin, S. E., & Lerner, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237108100 · Cited by 344
Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries
Söderlind, E., Strandberg, L., Jirholt, P., Kobayashi, N., Alexeiva, V., Åberg, A.-M., Nilsson, A., Jansson, B., Ohlin, M., Wingren, C., et al. (2000) · Nature Biotechnology · doi:10.1038/78458 · Cited by 337
Hu, S., Shively, L., Raubitschek, A. A., Sherman, M. A., Williams, L. E., Wong, J. Y., Shively, J. E., & Wu, A. M. (1996) · PubMed · Cited by 330
Pack, P., & Plueckthun, A. (1992) · Biochemistry · doi:10.1021/bi00121a001 · Cited by 291
Design and application of diabodies, triabodies and tetrabodies for cancer targeting
Todorovska, A., Roovers, R. C., Dolezal, O., Kortt, A. A., Hoogenboom, H. R., & Hudson, P. J. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00342-2 · Cited by 272
Proteolytic selection for protein folding using filamentous bacteriophages
Kristensen, P. K., & Winter, G. P. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00044-3 · Cited by 272
He, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.5132 · Cited by 266
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
Halin, C., Rondini, S., Nilsson, F., Berndt, A., Kosmehl, H., Zardi, L., & Neri, D. (2002) · Nature Biotechnology · doi:10.1038/nbt0302-264 · Cited by 252
Francisco, J. A., Campbell, R., Iverson, B. L., & Georgiou, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10444 · Cited by 251
Adams, G. P., McCartney, J. E., Tai, M.-S., Oppermann, H., Huston, J. S., Stafford, W. F., Bookman, M. A., Fand, I., Houston, L. L., & Weiner, L. M. (1993) · PubMed · Cited by 248
Rothe, C., Urlinger, S., Löhning, C., Prassler, J., Stark, Y., Jäger, U., Hubner, B., Bardroff, M., Pradel, I., Boss, M., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.12.018 · Cited by 247
Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty System
Singh, H., Manuri, P. R., Olivares, S., Dara, N., Dawson, M. J., Huls, H., Hackett, P. B., Kohn, D. B., Shpall, E. J., Champlin, R. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5600 · Cited by 246
Isotype selection in antibody engineering
Salfeld, J. G. (2007) · Nature Biotechnology · doi:10.1038/nbt1207-1369 · Cited by 239
Application of phage display to high throughput antibody generation and characterization
Schofield, D. J., Pope, A. R., Clementel, V., Buckell, J., Chapple, S. D., Clarke, K. F., Conquer, J. S., Crofts, A. M., Crowther, S. R., Dyson, M. R., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r254 · Cited by 236
Rossi, J. J., June, C. H., & Kohn, D. B. (2007) · Nature Biotechnology · doi:10.1038/nbt1367 · Cited by 231
Müller, D., Karle, A., Meißburger, B., Höfig, I., Stork, R., & Kontermann, R. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700820200 · Cited by 222
Phage display systems and their applications
Paschke, M. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0270-9 · Cited by 208
Levy, R., Weiss, R., Chen, G., Iverson, B. L., & Georgiou, G. (2001) · Protein Expression and Purification · doi:10.1006/prep.2001.1520 · Cited by 207 · cited 1×
“Using such strains, scFv have been produced at levels equal to or greater than those achieved with periplasmic expression (Levy et al., 2001).”
Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., Ikle, D. N., Yazaki, P. J., Chatziioannou, A. F., Gambhir, S. S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.622.65.2 · Cited by 206
Maynard, J., & Georgiou, G. (2000) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.2.1.339 · Cited by 206
Antibody affinity maturation using bacterial surface display
Daugherty, P. S., Chen, G., Olsen, M. J., Iverson, B. L., & Georgiou, G. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.9.825 · Cited by 199
Obstacles and pitfalls in the PEGylation of therapeutic proteins.
Gaberc‐Porekar, V., Zore, I., Podobnik, B., & Menart, V. (2008) · PubMed · Cited by 197
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
Holt, L. J., Basran, A., Jones, K., Chorlton, J., Jespers, L. S., Brewis, N. D., & Tomlinson, I. M. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm067 · Cited by 193
Design of multivalent complexes using the barnase·barstar module
Deyev, S. M., Waibel, R., Lebedenko, E. N., Schubiger, A. P., & Plückthun, A. (2003) · Nature Biotechnology · doi:10.1038/nbt916 · Cited by 191
Sachdev, D., Li, S. L., Hartell, J. S., Fujita‐Yamaguchi, Y., Miller, J. S., & Yee, D. (2003) · PubMed · Cited by 190
Hotte, S. J., Hirte, H. W., Chen, E. X., Siu, L. L., Le, L. H., Corey, A., Iacobucci, A., MacLean, M., Lo, L., Fox, N. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1416 · Cited by 190
Brischwein, K., Parr, L., Pflanz, S., Volkland, J., Lumsden, J., Klinger, M., Locher, M., Hammond, S. A., Kiener, P., Kufer, P., et al. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318156750c · Cited by 187 · cited 1×
“To address this concern, a recent study showed that T cell activation is dependent on the presence of cells expressing the proper target antigen and thus that these bispecific Ab constructs can elicit a controlled polyclonal T-cell therapy of, for example, cancer cells (Brischwein et al., 2007).”
Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities
Natsume, A., In, M., Takamura, H., Nakagawa, T., Shimizu, Y., Kitajima, K., Wakitani, M., Ohta, S., Satoh, M., Shitara, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6297 · Cited by 187
Elinav, E., Waks, T., & Eshhar, Z. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.060 · Cited by 180
Lu, D., Zhang, H., Koo, H., Tonra, J., Balderes, P., Prewett, M., Corcoran, E., Mangalampalli, V., Bassi, R., Anselma, D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500815200 · Cited by 180
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Garcia-Rodriguez, C., Levy, R., Arndt, J. W., Forsyth, C. M., Razai, A., Lou, J., Geren, I., Stevens, R. C., & Marks, J. D. (2007) · Nature Biotechnology · doi:10.1038/nbt1269 · Cited by 177
High-throughput generation and engineering of recombinant human antibodies
Krebs, B., Rauchenberger, R., Reiffert, S. U., Rothe, C., Tesar, M., Thomassen, E., Cao, M., Dreier, T., Fischer, D., Höss, A., et al. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00398-2 · Cited by 176
Supernatural T cells: genetic modification of T cells for cancer therapy
Kershaw, M. H., Teng, M. W. L., Smyth, M. J., & Darcy, P. K. (2005) · Nature reviews. Immunology · doi:10.1038/nri1729 · Cited by 175
M13 bacteriophage displaying disulfide-constrained microproteins
McLafferty, M. A., Kent, R. B., Ladner, R. C., & Markland, W. (1993) · Gene · doi:10.1016/0378-1119(93)90149-w · Cited by 175
Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting
Kortt, A. A., Dolezal, O., Power, B. E., & Hudson, P. J. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00090-9 · Cited by 173
Kruyt, F. A. E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.003 · Cited by 172
Selection of large diversities of antiidiotypic antibody fragments by phage display
Goletz, S., Christensen, P. A., Kristensen, P. K., Blohm, D. H., Tomlinson, I. M., Winter, G. P., & Karsten, U. R. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5314 · Cited by 162
Production technologies for monoclonal antibodies and their fragments
Andersen, D. C., & Reilly, D. E. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.08.002 · Cited by 162
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
Wolfgang, W. J., Miller, T. W., Webster, J. M., Huston, J. S., Thompson, L. M., Marsh, J., & Messer, A. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505321102 · Cited by 162
Rapid isolation of high-affinity protein binding peptides using bacterial display
Bessette, P. H., Rice, J. J., & Daugherty, P. S. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh084 · Cited by 155
Forero, A., Weiden, P. L., Vose, J. M., Knox, S. J., LoBuglio, A. F., Hankins, J. H., Goris, M. L., Picozzi, V. J., Axworthy, D. B., Breitz, H. B., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3284 · Cited by 155
Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective
Desjarlais, J. R., Lazar, G. A., Zhukovsky, E. A., & Chu, S. Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.009 · Cited by 154
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
Yang, Z., Wang, H., Zhao, J., Peng, Y., Wang, J., Guinn, B., & Huang, L. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701054 · Cited by 152
Huang, X., Guo, H., Kang, J., Choi, S., Zhou, T. C., Tammana, S., Lees, C. J., Li, Z.-Z., Milone, M. C., Levine, B. L., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300404 · Cited by 146
Nguyen, A., Reyes, A. E., Zhang, M., McDonald, P., Wong, W., Damico, L. A., & Dennis, M. S. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl011 · Cited by 141
Phage versus Phagemid Libraries for Generation of Human Monoclonal Antibodies
O’Connell, D. J., Becerril, B., Roy‐Burman, A., et al. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00561-2 · Cited by 141
Rauchenberger, R., Borges, E., Thomassen-Wolf, E., Rom, E., Adar, R., Yaniv, Y., Malka, M., Chumakov, I., Kotzer, S., Resnitzky, D., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303164200 · Cited by 139
Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides
Grönwall, C., Jonsson, A., Lindström, S., Gunneriusson, E., Ståhl, S., & Herne, N. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.09.013 · Cited by 138
Yang, K., Basu, A., Wang, M., Chintala, R., Hsieh, M.-C., Liu, S., Hua, J., Zhang, Z., Zhou, J. M., Li, M., et al. (2003) · Protein Engineering Design and Selection · doi:10.1093/protein/gzg093 · Cited by 136
Droogenbroeck, B. V., Cao, J., Stadlmann, J., Altmann, F., Colanesi, S., Hillmer, S., Robinson, D. G., Lerberge, E. V., Terryn, N., MONTAGU, M. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609997104 · Cited by 135
Shahied, L., Tang, Y., Alpaugh, R. K., Somer, R. A., Greenspon, D., & Weiner, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407888200 · Cited by 134
Immunotherapeutic perspective for bispecific antibodies
van Spriel, A. B., van Ojik, H. H., & van de Winkel, J. G. J. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01659-5 · Cited by 133
Eliminating helper phage from phage display
Chasteen, L., Ayriss, J. E., Pavlik, P., & Bradbury, A. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl772 · Cited by 131
Lynch, S. M., Zhou, C., & Messer, A. C. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.096 · Cited by 129
Engineering therapeutic monoclonal antibodies
Liu, X., Pop, L. M., & Vitetta, E. S. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00601.x · Cited by 128
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
Desplancq, D., King, D. J., Lawson, A. D. G., & Mountain, A. (1994) · Protein Engineering Design and Selection · doi:10.1093/protein/7.8.1027 · Cited by 127
A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz, J., Lin, Y., Sanderson, J., Zuo, Y., Stone, D. M., Mallett, R. W., Wilbert, S. M., & Axworthy, D. B. (2000) · PubMed · Cited by 127
Human IgG2 Can Form Covalent Dimers
Yoo, E. M., Wims, L. A., Chan, L. A., & Morrison, S. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3134 · Cited by 126
Sachdev, D., Singh, R., Fujita‐Yamaguchi, Y., & Yee, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3126 · Cited by 125
PEGylation and Multimerization of the Anti-p185HER-2 Single Chain Fv Fragment 4D5
Kubetzko, S., Balic, E., Waibel, R., Zangemeister‐Wittke, U., & Plückthun, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604127200 · Cited by 124
Construction, expression, and activity of a bivalent bispecific single-chain antibody.
Mallender, W. D., & Voss, E. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42334-9 · Cited by 120
Ghetie, M.-A., Podar, E. M., Ilgen, A., Gordon, B. E., Uhr, J. W., & Vitetta, E. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7509 · Cited by 118
Expression of human antibodies in eukaryotic micro-algae
Mayfield, S. P., & Franklin, S. E. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.013 · Cited by 117
β-site specific intrabodies to decrease and prevent generation of Alzheimer's Aβ peptide
Paganetti, P., Calanca, V., Galli, C., Stefani, M., & Molinari, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410047 · Cited by 115
Optimizing the affinity and specificity of proteins with molecular display
Levin, A. M., & Weiss, G. A. (2005) · Molecular BioSystems · doi:10.1039/b511782h · Cited by 114
Olafsen, T., Cheung, C. W., Yazaki, P. J., Li, L., Sundaresan, G., Gambhir, S. S., Sherman, M. A., Williams, L. E., Shively, J. E., Raubitschek, A. A., et al. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh009 · Cited by 114
The T-Body Approach: Redirecting T Cells with Antibody Specificity
Eshhar, Z. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_14 · Cited by 111
Miller, K. D., Weaver-Feldhaus, J., Gray, S. A., Siegel, R. W., & Feldhaus, M. J. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.04.015 · Cited by 111
Edwards, B. M., Barash, S. C., Main, S. H., Choi, G. H., Minter, R., Ullrich, S. J., Williams, E. M., Fou, L. D., Wilton, J., Albert, V. R., et al. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.054 · Cited by 111
Triabodies: Single chain Fv fragments without a linker form trivalent trimers
Iliades, P., Kortt, A. A., & Hudson, P. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00475-4 · Cited by 110 · cited 2×
“force scFv association into trimers (triabodies ~90 kDa) (Iliades et al., 1997) or tetramers (tetrabodies ~120 kDa) (Dolezal et al.”
A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm
Philibert, P., Stoessel, A., Wang, W., Sibler, A., Bec, N., Larroque, C., Saven, J. G., Courtête, J., Weiss, É., & Martineau, P. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-81 · Cited by 110
Schlapschy, M., Theobald, I., Mack, H. I. D., Schottelius, M., Wester, H.-J., & Skerra, A. (2007) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm020 · Cited by 107
Luginbühl, B., Kanyo, Z. F., Jones, R. M., Fletterick, R. J., Prusiner, S. B., Cohen, F. E., Williamson, R. A., Burton, D. R., & Plückthun, A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.07.027 · Cited by 106
Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin
Smith, B. J., Popplewell, A. G., Athwal, D., Chapman, A. P., Heywood, S. P., West, S. M., Carrington, B., Nesbitt, A. M., Lawson, A. D. G., Antoniw, P., et al. (2001) · Bioconjugate Chemistry · doi:10.1021/bc010003g · Cited by 105
Stork, R., Zettlitz, K. A., Müller, D., Rether, M., Hanisch, F., & Kontermann, R. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709179200 · Cited by 99
Jain, M., Chauhan, S. C., Singh, A. P., Venkatraman, G., Colcher, D. M., & Batra, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0662 · Cited by 98
Russel, M., & Model, P. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3284-3295.1989 · Cited by 97
Bremer, E., Samplonius, D. F., Peipp, M., van Genne, L., Kroesen, B., Fey, G. H., Gramatzki, M., de Leij, L. F. M. H., & Helfrich, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2756 · Cited by 96
Olafsen, T., Tan, G., Cheung, C. W., Yazaki, P. J., Park, J. M., Shively, J. E., Williams, L. E., Raubitschek, A. A., Press, M. F., & Wu, A. M. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh040 · Cited by 95
Kenanova, V. E., Olafsen, T., Williams, L. E., Ruel, N. H., Longmate, J., Yazaki, P. J., Shively, J. E., Colcher, D. M., Raubitschek, A. A., & Wu, A. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0454 · Cited by 94
Jendreyko, N., Popkov, M., Rader, C. M., & Barbas, C. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503168102 · Cited by 92
Harnessing phage and ribosome display for antibody optimisation
Dufner, P., Jermutus, L., & Minter, R. (2006) · Trends in biotechnology · doi:10.1016/j.tibtech.2006.09.004 · Cited by 92
Aires‐da‐Silva, F., Santa‐Marta, M., Freitas‐Vieira, A., Mascarenhas, P., Barahona, I., Moniz‐Pereira, J., Gabuzda, D. H., & Gonçalves, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.04.062 · Cited by 91
Chen, C., Snedecor, B., Nishihara, J. C., Joly, J. C., McFarland, N., Andersen, D. C., Battersby, J. E., & Champion, K. M. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20014 · Cited by 90
Fernández, L. Á., Sola, I., Enjuanes, L., & de Lorenzo, V. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.11.5024-5029.2000 · Cited by 90
Amann, M., Brischwein, K., Lutterbuese, P., Parr, L., Petersen, L., Lorenczewski, G., Krinner, E., Bruckmeier, S., Lippold, S., Kischel, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2182 · Cited by 90
Structural characterization of a mutated, ADCC-enhanced human Fc fragment
Oganesyan, V., Damschroder, M. M., Leach, W., Wu, H., & Dall’Acqua, W. F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.042 · Cited by 89
Thermal stabilization of a single‐chain Fv antibody fragment by introduction of a disulphide bond
Young, N. M., MacKenzie, C. R., Narang, S. A., Oomen, R. P., & Baenziger, J. E. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01325-3 · Cited by 87
Antibody production with yeasts and filamentous fungi: on the road to large scale?
Gasser, B., & Mattanovich, D. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9237-x · Cited by 86
Antibody processing and engineering in plants, and new strategies for vaccine production
K‐C., J., Drake, P. M. W., Chargelegue, D., Obregón, P., & Prada, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.011 · Cited by 84
A Focused Antibody Library for Improved Hapten Recognition
Persson, H., Lantto, J., & Ohlin, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.004 · Cited by 82
Stochastic modeling and optimization of phage display 1 1Edited by J. A. Wells
Levitan, B. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1555 · Cited by 81
Sharma, S. K., Pedley, R. B., Bhatia, J., Boxer, G. M., El‐Emir, E., Qureshi, U., Tolner, B., Lowe, H. L., Michael, N. P., Minton, N. P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.814.11.2 · Cited by 78
Cloutier, S. M., Couty, S., Terskikh, A. V., Marguerat, L., Crivelli, V., Pugnière, M., Mani, J. C., Leisinger, H., Mach, J. P., & Deperthes, D. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(01)00023-2 · Cited by 78
Müller, K. M., Arndt, K. M., Strittmatter, W., & Plückthun, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00021-0 · Cited by 78
A simple vector system to improve performance and utilisation of recombinant antibodies
Martin, C. D., Rojas, G., Mitchell, J. N., Vincent, K. J., Wu, J., McCafferty, J., & Schofield, D. J. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-46 · Cited by 78
A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes
Wyngaardt, W. V., Malatji, T., Mashau, C., Fehrsen, J., Jordaan, F., Miltiadou, D. R., & Plessis, D. H. D. (2004) · BMC Biotechnology · doi:10.1186/1472-6750-4-6 · Cited by 77
Merk, H., Stiege, W., Tsumoto, K., Kumagai, I., & Erdmann, V. A. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022290 · Cited by 76
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
Griffin, H. M., Elston, R., Jackson, D. J., Ansell, K. H., Coleman, M. M., Winter, G. P., & Doorbar, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.077 · Cited by 76
Biodistribution and tumor imaging of an anti-CEA single-chain antibody–albumin fusion protein
Yazaki, P. J., Kassa, T., Cheung, C. W., Crow, D. M., Sherman, M. A., Bading, J. R., Anderson, A.-L. J., Colcher, D. M., & Raubitschek, A. A. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.10.010 · Cited by 76
Hackel, B. J., Huang, D., Bubolz, J. C., Wang, X. X., & Shusta, E. V. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9778-7 · Cited by 75
Ribosome display: next-generation display technologies for production of antibodiesin vitro
He, M., & Khan, F. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.3.421 · Cited by 74
The use of scFv-displaying yeast in mammalian cell surface selections
Wang, X. X., & Shusta, E. V. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.05.006 · Cited by 73
Synthetic Antibody Libraries Focused Towards Peptide Ligands
Cobaugh, C. W., Almagro, J. C., Pogson, M., Iverson, B. L., & Georgiou, G. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.037 · Cited by 68
Affinity maturation of phage display antibody populations using ribosome display
Groves, M. A. T., Lane, S., Douthwaite, J. A., Lowne, D., Rees, D. G., Edwards, B. M., & Jackson, R. H. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.04.002 · Cited by 67
Compte, M., Blanco, B., Serrano, F., Cuesta, Á. M., Sanz, L., Bernad, A., Holliger, P., & Álvarez‐Vallina, L. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701021 · Cited by 65
Guo, J., Shangyou, Y., Li, L., Zhang, Y.-Z., Huang, J.-N., & Zhang, C. (2003) · Journal of Biotechnology · doi:10.1016/s0168-1656(03)00020-8 · Cited by 64
Rosenfeld, R., Valensi, M., & Benhar, I. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.053 · Cited by 64
Lin, Y., Pagel, J. M., Axworthy, D. B., Pantelias, A., Hedin, N., & Press, O. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3443 · Cited by 63
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Ferl, G. Z., Kenanova, V. E., Wu, A. M., & DiStefano, J. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0072 · Cited by 62
Modulation of Antibody Pharmacokinetics by Chemical Polysialylation
Constantinou, A., Epenetos, A. A., Hreczuk-Hirst, D., Jain, S., & Deonarain, M. P. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700319r · Cited by 62
Böldicke, T. W. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00002.x · Cited by 62
Blanco, B., Holliger, P., Vile, R. G., & Álvarez‐Vallina, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1070 · Cited by 59
Asano, R., Watanabe, Y., Kawaguchi, H., Fukazawa, H., Nakanishi, T., Umetsu, M., Hayashi, H., Katayose, Y., Unno, M., Kudo, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704719200 · Cited by 59
Development of Multivalent Radioimmunonanoparticles for Cancer Imaging and Therapy
Natarajan, A., Xiong, C., Gruettner, C., DeNardo, G. L., & DeNardo, S. J. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0410 · Cited by 58
Swennen, D., Paul, M.-F., Vernis, L., et al. (2002) · Microbiology · doi:10.1099/00221287-148-1-41 · Cited by 51
Pagel, J. M., Lin, Y., Hedin, N., Pantelias, A., Axworthy, D. B., Stone, D. M., Hamlin, D. K., Wilbur, D. S., & Press, O. W. (2006) · Blood · doi:10.1182/blood-2005-11-4327 · Cited by 51
Bruenke, J., Fischer, B. E., Barbin, K., Schreiter, K., Wachter, Y., Mahr, K., Titgemeyer, F., Niederweis, M., Peipp, M., Zunino, S. J., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04893.x · Cited by 51
Glyco-engineering of Biotherapeutic Proteins in Plants
Ko, K., Ahn, M., Song, M., Choo, Y., Kim, H. S., Ko, K., & Joung, H. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)17610-2 · Cited by 50
Wawrzynczak, E. J., Henry, R., Cumber, A. J., Parnell, G. D., Derbyshire, E. J., & ULBRICH, N. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb15805.x · Cited by 47
Natsume, A., Wakitani, M., Yamane‐Ohnuki, N., Shoji-Hosaka, E., Niwa, R., Uchida, K., Satoh, M., & Shitara, K. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj157 · Cited by 46
Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic system
He, M., & Taussig, M. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.11.022 · Cited by 46
Makvandi‐Nejad, S., McLean, M. D., Hirama, T., Almquist, K. C., MacKenzie, C. R., & Hall, J. C. (2005) · Transgenic Research · doi:10.1007/s11248-005-7461-0 · Cited by 44
Self-citationTargeting TNF-α with a tetravalent mini-antibody TNF-TeAb
Liu, M., Wang, X., Yin, C., Zhang, Z., Lin, Q., Zhen, Y., & Hualiang, H. (2007) · Biochemical Journal · doi:10.1042/bj20070149 · Cited by 40
Morecki, S., Lindhofer, H., Yacovlev, E., Gelfand, Y., Ruf, P., & Slavin, S. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.03.005 · Cited by 38
Yamawaki, S., Matsumoto, T., Ohnishi, Y., Kumada, Y., Shiomi, N., Katsuda, T., Lee, E. K., & Katoh, S. (2007) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.104.403 · Cited by 36
Guo, J., Li, Q., Zhou, J., Zhang, G., Yang, Y., Xing, G., Zhao, D. F., Shangyou, Y., & Zhang, C. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.05.016 · Cited by 35
Dolezal, O., Gori, R. D., Walter, M., Doughty, L., Hattarki, M. K., Hudson, P. J., & Kortt, A. A. (2003) · Protein Engineering Design and Selection · doi:10.1093/proeng/gzg006 · Cited by 34
Martínez, L. M. C., & DeLisa, M. P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.070 · Cited by 33
McLean, M. D., Almquist, K. C., Niu, Y., Kimmel, R., Lai, Z., Schreiber, J. R., & Hall, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-07 · Cited by 32
Self-citationChodorge, M., Fourage, L., Ravot, G., Jermutus, L., & Minter, R. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzn013 · Cited by 30
Krinner, E.-M., Hepp, J., Hoffmann, P., Bruckmaier, S., Petersen, L., Petsch, S., Parr, L., Schuster, I., Mangold, S., Lorenczewski, G., et al. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl031 · Cited by 30
Padiolleau‐Lefèvre, S., Debat, H., Phichith, D., Daniel, T., Friboulet, A., & Avalle, B. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.10.010 · Cited by 29
Li, S., Yang, J., Urban, F. A., et al. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.5 · Cited by 29
Wang, X.-B. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh065 · Cited by 29
Yoshinaga, K., Matsumoto, M., Torikai, M., Sugyo, K., Kuroki, S., Nogami, K., Matsumoto, R., Hashiguchi, S., Ito, Y., Nakashima, T., et al. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn009 · Cited by 29
Comparative expression of different antibody formats in mammalian cells and Pichia pastoris
Braren, I., Greunke, K., Umland, O., Deckers, S., Bredehorst, R., & Spillner, E. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060170 · Cited by 26
Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display
Rothe, A., Nathanielsz, A., Hosse, R. J., Oberhauser, F., von Strandmann, E. P., Engert, A., Hudson, P. J., & Power, B. E. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.05.012 · Cited by 25
Westwood, J. A., Murray, W. K., Trivett, M., Shin, A., Neeson, P. J., MacGregor, D. P., Haynes, N. M., Trapani, J. A., Mayura-Guru, P., Fox, S. B., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.47 · Cited by 25
Wang, H., Dai, J., Li, B., Fan, K., Peng, L., Zhang, D., Cao, Z., Qian, W., Wang, H., Zhao, J., et al. (2007) · Protein Expression and Purification · doi:10.1016/j.pep.2007.09.009 · Cited by 20
Moisini, I., Nguyen, P., Fugger, L. H., & Geiger, T. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3601 · Cited by 17
Schneider, M. A., Brühl, H., Wechselberger, A., Cihak, J., Stangassinger, M., Schlöndorff, D., & Mack, M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425512 · Cited by 15
Cited by
Considerations for the Design of Antibody-Based Therapeutics
Goulet, D. R., & Atkins, W. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.031 · Cited by 302
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
Suurs, F. V., Lub-de Hooge, M. N., de Vries, E. G. E., & de Groot, D. J. A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.006 · Cited by 292
Delivering the promise of miRNA cancer therapeutics
Pereira, D. M., Rodrigues, P. M., Borralho, P. M., & Rodrigues, C. M. P. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.002 · Cited by 288
Advanced in developmental organic and inorganic nanomaterial: a review
Khalid, K., Tan, X., Mohd Zaid, H. F., Tao, Y., Lye Chew, C., Chu, D.-T., Lam, M. K., Ho, Y.-C., Lim, J. W., & Chin Wei, L. (2020) · Bioengineered · doi:10.1080/21655979.2020.1736240 · Cited by 263
Advances in the production and batch reformatting of phage antibody libraries
Reader, R. H., Workman, R. G., Maddison, B. C., & Gough, K. C. (2019) · Molecular Biotechnology · doi:10.1007/s12033-019-00207-0 · Cited by 41
Metadata
- Authors
- Weisser, N. E., & Hall, J. C.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 27
- Issue
- 4
- Pages
- 502-520
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2042548343
- Cited by
- 261
- References
- 182
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.